News

­

Hera Biolabs announces Molecular Cancer Therapeutics publication on immunodeficient rats for oncology research

Hera Biolabs, the University of Michigan, Case Western Reverse University [...]

By |October 19th, 2018|

OncoRat® PDX models highlighted in Drug Discovery News (DDN) Special Report on Cancer: Aiming for Avatars

While advances in in-vitro platforms have allowed researchers to better [...]

By |July 18th, 2018|

Humanized immune-system SRG Rats™ & mice for immuno-oncology

The SRG rat demonstrates robust immune-system humanization with peripheral blood [...]

By |January 29th, 2018|

Hera Presents at SOT 2017 & AACR 2017 Recap

Hera strives to provide its clients with superior preclinical toxicology [...]

By |April 27th, 2017|

Chimeric Humanized Mouse Models: Understanding Human and Mouse Cell Interactions

Humanized liver mouse models are increasingly being used in preclinical [...]

By |February 28th, 2017|

Transposon Mutagenesis Helps Identify Genes Mediating Drug Resistance in the Treatment of CLL

First time treatment of Chronic Lymphocratic Leukemia (CLL) generally requires [...]

By |February 28th, 2017|

PDX Models of Lung Cancer Closely Mimic Characteristics of Patient Primary Tumors

Despite ongoing research, lung cancers have remained among the most [...]

By |February 28th, 2017|

Rat Provides a More Robust & Convenient Animal Infection Model for Hepatitis E Virus

Hepatitis E virus (HEV) is estimated to cause more than [...]

By |December 21st, 2016|

Hera BioLabs, a KY based contract research lab announces $400K Kentucky SBIR/STTR Matching Funds Grant

Hera BioLabs (“Hera”), a Lexington KY based contract research organization [...]

By |December 14th, 2016|

Hera BioLabs in Genetic Engineering News

Hera BioLabs and our VP of Research and Development Tseten [...]

By |October 28th, 2016|